# NHLBI and Cook Trans-Atrial Intra-Pericardial Tricuspid Annuloplasty (TRAIPTA) Early Feasibility Study

> **NCT06479824** · NA · SUSPENDED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 60 (estimated)

## Conditions studied

- Tricuspid Valve Insufficiency

## Interventions

- **DEVICE:** TRAIPTA (Trans-Atrial Intra-Pericardial Tricuspid Annuloplasty)

## Key facts

- **NCT ID:** NCT06479824
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2025-08-19
- **Primary completion:** 2026-10-01
- **Final completion:** 2030-09-01
- **Target enrollment:** 60 (ESTIMATED)
- **Why stopped:** Enrollment has been put on hold by the sponsor to allow for further engineering evaluation and performance review of the investigational device, as well as reassessment of the underlying device reliability assumptions.
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06479824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06479824, "NHLBI and Cook Trans-Atrial Intra-Pericardial Tricuspid Annuloplasty (TRAIPTA) Early Feasibility Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06479824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*